KLRS

Kalaris TherapeuticsA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

KLRS vs peer average

95/100

KLRS vs. peer average (A vs. D)

Grade spread

C 1 · D 3 · F 4

Graded peers loaded

Coverage

8 graded

100% of tracked

Peer overview

ACRV is the first available peer comparator.

Same-sector market-cap comparator near KLRS's size; useful for micro-cap biotech event-volatility framing, not a direct TH103 or AMD peer.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerACRVAcrivon Therapeutics

KLRS

Kalaris Therapeutics

ACRV

Acrivon Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs ACRV

KLRS / ACRV

Grade Position

Above peers

KLRS vs. peer average (A vs. D)

95/100

Momentum

ACRV

Value

KLRS

Sentiment

KLRS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs KLRS

20/100

20/100

60/100

40/100

40/100

ACRV is the first peer returned for this comparison set.